# Reasoning-mode run — next_event — qid `ehr_bench_decision_making_7062`

- **gold label:** `radiology`
- **final prediction:** `['radiology']`

## Rendered user prompt (what the model saw)
```
<task_instruction>
Given the sequence of events that have occurred in a hospital, please give the next event suggestion for the patients.
All patient events needed for this task are already included below.
The current time is 2163-03-21 14:00:01, which is exactly one second after the latest observed event at 2163-03-21 14:00:00.
Use only the provided patient timeline.
Do not assume any unseen future events beyond the current time.
No EHR database lookup is needed for this record because the full timeline is embedded in the prompt.
Return only the final answer text as a single line. If candidate answers are provided, choose only from that candidate list.
</task_instruction>

<patient_info>
Current Time: 2163-03-21 14:00:01
</patient_info>

<patient_timeline>
## Patient Demographics [None]
- Anchor_Age: 77
- Gender: M







## Microbiology Test Events [None]
- Test_Name: Blood Culture, Routine
- Dilution_Text: nan
- Interpretation: nan
- Comments: nan
- Ab_Name: nan

## Online Medical Record [2161-01-26 00:00:00]
| Result_Name | Result_Value |
| ------ | ------ |
| BMI (kg/m2) | 22.1 |
| Weight (Lbs) | 137 |

## Radiology Examinations [2161-01-26 09:28:00]
- Note_Type: RR
- Exam_Name: ['ABDOMEN US (COMPLETE STUDY)']
- Text: EXAMINATION:  ABDOMEN US (COMPLETE STUDY)

INDICATION:  ___ year old man with chronic HBV and cirrhosis // ___
surveillance

TECHNIQUE:  Grey scale ultrasound images of the abdomen were obtained.

COMPARISON:  Abdomen ultrasound ___

FINDINGS: 

LIVER: The liver is nodular in appearance consistent with the patient's known
cirrhosis. There is no focal liver mass.  The main portal vein is patent with
hepatopetal flow. There is no ascites.

BILE DUCTS: There is no intrahepatic biliary dilation. The CBD measures 0.7
cm.

GALLBLADDER: Several small polyps measuring up to 3 mm in size are again
vizualized in the gallbladder. A small hepatic cyst is again noted adjacent to
the gallbladder measuring 7 mm.

PANCREAS: The pancreas is unremarkable but is only minimally visualized due to
overlying bowel gas.

SPLEEN: The spleen is borderline in size measuring 13.0 cm.

KIDNEYS: No hydronephrosis is seen in either kidney. The right kidney measures
10.7 cm and the left kidney measures 10.2 cm.

RETROPERITONEUM: The aorta is obscured from view by bowel gas. The visualized
portion of the IVC is within normal limits.

IMPRESSION:



1. Nodular hepatic architecture consistent with cirrhosis. No focal liver
lesion identified.
2. Small gallbladder polyps again incidentally noted and a small stable cyst
is seen in the liver adjacent to the gallbladder.


## Labotary Test Events [2161-01-26 12:05:00]
| Item_Name | Valuenum | Valueuom | Ref_Range_Lower | Ref_Range_Upper | Flag | Comments |
| ------ | ------ | ------ | ------ | ------ | ------ | ------ |
| Basophils | 0.7 | % | 0.0 | 2.0 | nan | nan |
| Eosinophils | 1.7 | % | 0.0 | 4.0 | nan | nan |
| Hematocrit | 45.7 | % | 40.0 | 52.0 | nan | nan |
| Hemoglobin | 14.6 | g/dL | 14.0 | 18.0 | nan | nan |
| Lymphocytes | 31.3 | % | 18.0 | 42.0 | nan | nan |
| MCH | 33.0 | pg | 27.0 | 32.0 | abnormal | nan |
| MCHC | 32.0 | % | 31.0 | 35.0 | nan | nan |
| MCV | 103.0 | fL | 82.0 | 98.0 | abnormal | nan |
| Monocytes | 4.9 | % | 2.0 | 11.0 | nan | nan |
| Neutrophils | 61.3 | % | 50.0 | 70.0 | nan | nan |
| Platelet Count | 47.0 | K/uL | 150.0 | 440.0 | abnormal | ___ |
| RDW | 14.2 | % | 10.5 | 15.5 | nan | nan |
| Red Blood Cells | 4.44 | m/uL | 4.6 | 6.2 | abnormal | nan |
| White Blood Cells | 3.9 | K/uL | 4.0 | 11.0 | abnormal | nan |
| Alanine Aminotransferase (ALT) | 32.0 | IU/L | 0.0 | 40.0 | nan | nan |
| Albumin | 4.6 | g/dL | 3.5 | 5.2 | nan | nan |
| Alkaline Phosphatase | 78.0 | IU/L | 40.0 | 130.0 | nan | nan |
| Alpha-Fetoprotein | 60.1 | ng/mL | 0.0 | 8.7 | abnormal | MEASURED BY ___. |
| Asparate Aminotransferase (AST) | 36.0 | IU/L | 0.0 | 40.0 | nan | nan |
| Bilirubin, Direct | 0.4 | mg/dL | 0.0 | 0.3 | abnormal | nan |
| Bilirubin, Indirect | 0.9 | mg/dL | nan | nan | nan | nan |
| Bilirubin, Total | 1.3 | mg/dL | 0.0 | 1.5 | nan | nan |
| Cholesterol Ratio (Total/HDL) | 1.9 | Ratio | nan | nan | nan | nan |
| Cholesterol, HDL | 64.0 | mg/dL | nan | nan | nan | nan |
| Cholesterol, LDL, Calculated | 44.0 | mg/dL | 0.0 | 129.0 | nan | nan |
| Cholesterol, Total | 119.0 | mg/dL | 0.0 | 199.0 | nan | nan |
| Creatinine | 1.3 | mg/dL | 0.5 | 1.2 | abnormal | nan |
| Estimated GFR (MDRD equation) | nan | nan | nan | nan | nan | Using this patient's age, gender, and serum creatinine value of 1.3,.  Estimated GFR = 54 if non African-American (mL/min/1.73 m2).  Estimated GFR = 65 if African-American (mL/min/1.73 m2).  For comparison, mean GFR for age group 70+ is 75 (mL/min/1.73 m2).  GFR<60 = Chronic Kidney Disease, GFR<15 = Kidney Failure. |
| Globulin | 3.1 | g/dL | 2.0 | 4.0 | nan | nan |
| Protein, Total | 7.7 | g/dL | 6.4 | 8.3 | nan | nan |
| Triglycerides | 57.0 | mg/dL | 0.0 | 149.0 | nan | LDL(CALC) INVALID IF TRIG>400 OR NON-FASTING SAMPLE. |
| Urea Nitrogen | 19.0 | mg/dL | 6.0 | 20.0 | nan | nan |
| Glucose | 106.0 | mg/dL | 70.0 | 100.0 | abnormal | IF FASTING, 70-100 NORMAL, >125 PROVISIONAL DIABETES. |
| % Hemoglobin A1c | 6.0 | % | 4.8 | 5.9 | abnormal | ADA RECOMMENDATIONS:;  <7%  GOAL OF THERAPY;  >8%  WARRANTS THERAPEUTIC ACTION. |
| eAG | 126.0 | mg/dL | 91.0 | 123.0 | abnormal | ___ |
| INR(PT) | 1.1 | nan | 0.9 | 1.1 | nan | nan |
| PT | 12.1 | sec | 9.4 | 12.5 | nan | nan |
| PTT | 39.4 | sec | 25.0 | 36.5 | abnormal | nan |
| Albumin, Urine | 0.5 | mg/dL | nan | nan | nan | nan |
| Albumin/Creatinine, Urine | 6.3 | mg/g | 0.0 | 30.0 | nan | nan |
| Creatinine, Urine | 79.0 | mg/dL | nan | nan | nan | nan |
| Length of Urine Collection | nan | nan | nan | nan | nan | RANDOM. |
| Red Top Hold | nan | nan | nan | nan | nan | HOLD. |

## Microbiology Test Events [2161-01-26 12:05:00]
- Test_Name: HBV Viral Load
- Dilution_Text: nan
- Interpretation: nan
- Comments: HBV DNA not detected.  Performed using the ___ HBV Test v2.0.  Linear range of quantification: 20 IU/mL - 170 million IU/mL.  Limit of detection: 20 IU/mL.  
- Ab_Name: nan

## Online Medical Record [2161-09-02 00:00:00]
| Result_Name | Result_Value |
| ------ | ------ |
| Blood Pressure | 110/70 |
| BMI (kg/m2) | 23.6 |
| Weight (Lbs) | 146 |

## Radiology Examinations [2161-09-02 13:01:00]
- Note_Type: RR
- Exam_Name: ['LIVER OR GALLBLADDER US (SINGLE ORGAN)']
- Text: EXAMINATION:  ABDOMEN US (COMPLETE STUDY)

INDICATION:  ___ year old man with chronic HBV  // HCC Surveillance

TECHNIQUE:  Grey scale and color Doppler ultrasound images of the abdomen were
obtained.

COMPARISON:  Ultrasound performed on ___.

FINDINGS: 

LIVER: The liver is coarsened and nodular in echotexture.The contour of the
liver is smooth. There is no focal liver mass. Main portal vein is patent with
hepatopetal flow. There is no ascites.

BILE DUCTS: There is no intrahepatic biliary dilation. The CBD measures 5 mm.

GALLBLADDER: There is no evidence of stones or gallbladder wall thickening. 
Note is made of a 4 mm gallbladder polyp at the fundus.

PANCREAS: Imaged portion of the pancreas appears within normal limits, without
masses or pancreatic ductal dilation, with portions of the pancreatic tail
obscured by overlying bowel gas.

SPLEEN: Normal echogenicity, measuring 13.7 cm.

KIDNEYS: The right kidney measures 10.2 cm. The left kidney measures 10 cm.
Normal cortical echogenicity and corticomedullary differentiation is seen
bilaterally. There is no evidence of masses, stones or hydronephrosis in the
kidneys.

RETROPERITONEUM: Visualized portions of aorta and IVC are within normal
limits.

IMPRESSION: 

1. Coarsened liver echotexture, stable from the previous exam.  No suspicious
hepatic lesions.
2. Splenomegaly.


## Labotary Test Events [2161-09-02 15:35:00]
| Item_Name | Valuenum | Valueuom | Ref_Range_Lower | Ref_Range_Upper | Flag | Comments |
| ------ | ------ | ------ | ------ | ------ | ------ | ------ |
| % Hemoglobin A1c | 6.5 | % | 4.8 | 5.9 | abnormal | ADA RECOMMENDATIONS:;  <7%  GOAL OF THERAPY;  >8%  WARRANTS THERAPEUTIC ACTION. |
| eAG | 140.0 | mg/dL | 91.0 | 123.0 | abnormal | ___ |
| Alanine Aminotransferase (ALT) | 28.0 | IU/L | 0.0 | 40.0 | nan | nan |
| Albumin | 4.4 | g/dL | 3.5 | 5.2 | nan | nan |
| Alkaline Phosphatase | 74.0 | IU/L | 40.0 | 130.0 | nan | nan |
| Alpha-Fetoprotein | 3.1 | ng/mL | 0.0 | 8.7 | nan | MEASURED BY ___. |
| Asparate Aminotransferase (AST) | 37.0 | IU/L | 0.0 | 40.0 | nan | nan |
| Bilirubin, Direct | 0.4 | mg/dL | 0.0 | 0.3 | abnormal | nan |
| Bilirubin, Indirect | 1.2 | mg/dL | nan | nan | nan | nan |
| Bilirubin, Total | 1.6 | mg/dL | 0.0 | 1.5 | abnormal | nan |
| Creatinine | 1.2 | mg/dL | 0.5 | 1.2 | nan | nan |
| Estimated GFR (MDRD equation) | nan | nan | nan | nan | nan | Using this patient's age, gender, and serum creatinine value of 1.2,.  Estimated GFR = 59 if non African-American (mL/min/1.73 m2).  Estimated GFR = 71 if African-American (mL/min/1.73 m2).  For comparison, mean GFR for age group 70+ is 75 (mL/min/1.73 m2).  GFR<60 = Chronic Kidney Disease, GFR<15 = Kidney Failure. |
| Globulin | 3.2 | g/dL | 2.0 | 4.0 | nan | nan |
| Protein, Total | 7.6 | g/dL | 6.4 | 8.3 | nan | nan |
| Urea Nitrogen | 14.0 | mg/dL | 6.0 | 20.0 | nan | nan |
| INR(PT) | 1.2 | nan | 0.9 | 1.1 | abnormal | nan |
| PT | 12.9 | sec | 9.4 | 12.5 | abnormal | nan |
| Basophils | 0.4 | % | 0.0 | 2.0 | nan | nan |
| Eosinophils | 1.7 | % | 0.0 | 4.0 | nan | nan |
| Hematocrit | 41.0 | % | 40.0 | 52.0 | nan | nan |
| Hemoglobin | 14.0 | g/dL | 14.0 | 18.0 | nan | nan |
| Lymphocytes | 33.2 | % | 18.0 | 42.0 | nan | nan |
| MCH | 32.1 | pg | 27.0 | 32.0 | abnormal | nan |
| MCHC | 34.2 | % | 31.0 | 35.0 | nan | nan |
| MCV | 94.0 | fL | 82.0 | 98.0 | nan | nan |
| Monocytes | 5.5 | % | 2.0 | 11.0 | nan | nan |
| Neutrophils | 59.2 | % | 50.0 | 70.0 | nan | nan |
| Platelet Count | 54.0 | K/uL | 150.0 | 440.0 | abnormal | nan |
| RDW | 14.3 | % | 10.5 | 15.5 | nan | nan |
| Red Blood Cells | 4.37 | m/uL | 4.6 | 6.2 | abnormal | nan |
| White Blood Cells | 4.1 | K/uL | 4.0 | 11.0 | nan | nan |

## Microbiology Test Events [2161-09-02 15:35:00]
- Test_Name: HBV Viral Load
- Dilution_Text: nan
- Interpretation: nan
- Comments: HBV DNA detected, less than 20 IU/mL.  Performed using the ___ HBV Test v2.0.  Linear range of quantification: 20 IU/mL - 170 million IU/mL.  Limit of detection: 20 IU/mL.  
- Ab_Name: nan

## Online Medical Record [2161-11-08 00:00:00]
- Result_Name: Blood Pressure
- Result_Value: 90/50

## Labotary Test Events [2161-11-08 10:19:00]
| Item_Name | Valuenum | Valueuom | Ref_Range_Lower | Ref_Range_Upper | Flag | Comments |
| ------ | ------ | ------ | ------ | ------ | ------ | ------ |
| Creatinine | 1.3 | mg/dL | 0.5 | 1.2 | abnormal | nan |
| Estimated GFR (MDRD equation) | nan | nan | nan | nan | nan | Using this patient's age, gender, and serum creatinine value of 1.3,.  Estimated GFR = 54 if non African-American (mL/min/1.73 m2).  Estimated GFR = 65 if African-American (mL/min/1.73 m2).  For comparison, mean GFR for age group 70+ is 75 (mL/min/1.73 m2).  GFR<60 = Chronic Kidney Disease, GFR<15 = Kidney Failure. |
| Urea Nitrogen | 18.0 | mg/dL | 6.0 | 20.0 | nan | nan |
| % Hemoglobin A1c | 6.6 | % | 4.8 | 5.9 | abnormal | ADA RECOMMENDATIONS:;  <7%  GOAL OF THERAPY;  >8%  WARRANTS THERAPEUTIC ACTION. |
| eAG | 143.0 | mg/dL | 91.0 | 123.0 | abnormal | ___ |
| Glucose | 135.0 | mg/dL | 70.0 | 100.0 | abnormal | IF FASTING, 70-100 NORMAL, >125 PROVISIONAL DIABETES. |

## Radiology Examinations [2161-11-30 07:56:00]
- Note_Type: RR
- Exam_Name: ['MRI ABDOMEN W/O & W/CONTRAST']
- Text: EXAMINATION:  MRI ABDOMEN W/O AND W/CONTRAST

INDICATION:  ___ year old man with cirrhosis secondary to HBV. elevated AFP  //
___ surveillance

TECHNIQUE:   Multiplanar, multi sequence imaging at 1.5 Tesla. T1 and T2
weighted images, in addition to dynamic imaging before and after
administration of 6 CC GADAVIST IV.

COMPARISON:  Multiple prior ultrasounds, most recent ___

FINDINGS: 

No pleural effusions.

Cirrhotic appearing liver with capsular nodularity, shrunken right lobe and
fissural widening.  A 2.1 x 2.4 cm lesion within segment 4A/8 demonstrates
foci of arterial hyperenhancement with washout and pseudo capsule, compatible
with OPTN 5B.  Other small subcentimeter foci of arterial enhancement
demonstrate isointensity on other sequences, likely perfusion anomalies. 
Scattered small hepatic cysts/biliary hamartomas are also present.  Patent
portal veins.  Perisplenic, perigastric and periesophageal varices are noted
along with a splenorenal shunt.

Splenomegaly, 13.6 cm.  Normal adrenals.

A 4 mm cystic appearing lesion is noted within the pancreatic head, possible
sidebranch IPMN.  No main pancreatic ductal dilation or apparent pancreatic
mass.

No hydronephrosis.  Small subcentimeter bilateral renal cysts are noted, many
of which are subcapsular in location, raising the possibility of
glomerulocystic renal disease.

Normal caliber abdominal aorta.  No retroperitoneal or mesenteric adenopathy. 
Decompressed stomach with ingested material.  Visualized bowel loops are
unremarkable.

No suspicious osseous lesions.

IMPRESSION:


-2.31x 2.4 cm segment 4A/8 lesion is compatible with ___, OPTN Class 5B.  No
other suspicious liver lesions.
-Cirrhotic appearing liver with sequelae of portal hypertension.
-4 mm cystic pancreatic lesion, possible sidebranch IPMN.  This can followed
on subsequent imaging.
-Small subcentimeter, subcapsular bilateral renal cysts, raising possibility
of glomerulocystic renal disease.


## Transfers [2162-01-04 20:35:00]
- Eventtype: ED
- Careunit: Emergency Department

## EDstays [2162-01-04 20:35:00]
- Gender: M
- Race: ASIAN - CHINESE

## Triage [2162-01-04 20:35:01]
- Temperature: 99.2
- Heartrate: 82.0
- Resprate: 16.0
- O2Sat: 100.0
- Sbp: 95.0
- Dbp: 64.0
- Pain: 13
- Acuity: 3.0
- Chiefcomplaint: Fever, Headache

## Radiology Examinations [2162-01-04 21:12:00]
- Note_Type: RR
- Exam_Name: ['CHEST (PA & LAT)']
- Text: EXAMINATION:  CHEST (PA AND LAT)

INDICATION:  ___ with fever

COMPARISON:  None

FINDINGS: 

PA and lateral views of the chest provided.

There is no focal consolidation, effusion, or pneumothorax. The
cardiomediastinal silhouette is normal. Imaged osseous structures are intact. 
No free air below the right hemidiaphragm is seen.

IMPRESSION: 

No acute intrathoracic process.


## Labotary Test Events [2162-01-04 21:50:00]
| Item_Name | Valuenum | Valueuom | Ref_Range_Lower | Ref_Range_Upper | Flag | Comments |
| ------ | ------ | ------ | ------ | ------ | ------ | ------ |
| Lactate | 1.8 | mmol/L | 0.5 | 2.0 | nan | GREEN TOP TUBE. |
| Blue Top Hold | nan | nan | nan | nan | nan | ___ |
| Alanine Aminotransferase (ALT) | 32.0 | IU/L | 0.0 | 40.0 | nan | nan |
| Albumin | 4.0 | g/dL | 3.5 | 5.2 | nan | nan |
| Alkaline Phosphatase | 77.0 | IU/L | 40.0 | 130.0 | nan | nan |
| Anion Gap | 18.0 | mEq/L | 8.0 | 20.0 | nan | nan |
| Asparate Aminotransferase (AST) | 45.0 | IU/L | 0.0 | 40.0 | abnormal | nan |
| Bicarbonate | 25.0 | mEq/L | 22.0 | 32.0 | nan | nan |
| Bilirubin, Total | 0.8 | mg/dL | 0.0 | 1.5 | nan | nan |
| Chloride | 98.0 | mEq/L | 96.0 | 108.0 | nan | nan |
| Creatinine | 1.4 | mg/dL | 0.5 | 1.2 | abnormal | nan |
| Estimated GFR (MDRD equation) | nan | nan | nan | nan | nan | Using this patient's age, gender, and serum creatinine value of 1.4,.  Estimated GFR = 49 if non African-American (mL/min/1.73 m2).  Estimated GFR = 60 if African-American (mL/min/1.73 m2).  For comparison, mean GFR for age group 70+ is 75 (mL/min/1.73 m2).  GFR<60 = Chronic Kidney Disease, GFR<15 = Kidney Failure. |
| Glucose | 233.0 | mg/dL | 70.0 | 100.0 | abnormal | IF FASTING, 70-100 NORMAL, >125 PROVISIONAL DIABETES. |
| Potassium | 4.6 | mEq/L | 3.3 | 5.1 | nan | nan |
| Sodium | 136.0 | mEq/L | 133.0 | 145.0 | nan | nan |
| Urea Nitrogen | 13.0 | mg/dL | 6.0 | 20.0 | nan | nan |
| Absolute Lymphocyte Count | 0.88 | K/uL | 1.2 | 3.7 | abnormal | nan |
| Basophils | 0.3 | % | 0.0 | 1.0 | nan | nan |
| Blood Parasite Smear | nan | nan | nan | nan | nan | THIN AND THICK SMEARS REVIEWED.  IF HIGH CLINICAL SUSPICION OF MALARIA; REPEAT SCREEN EVERY 12-24 HOURS FOR 3 CONSECUTIVE DAYS. |
| Eosinophils | 0.9 | % | 1.0 | 7.0 | abnormal | nan |
| Hematocrit | 41.8 | % | 40.0 | 51.0 | nan | nan |
| Hemoglobin | 13.8 | g/dL | 13.7 | 17.5 | nan | nan |
| Lymphocytes | 27.0 | % | 19.0 | 53.0 | nan | nan |
| MCH | 31.4 | pg | 26.0 | 32.0 | nan | nan |
| MCHC | 33.0 | g/dL | 32.0 | 37.0 | nan | nan |
| MCV | 95.0 | fL | 82.0 | 98.0 | nan | nan |
| Monocytes | 19.0 | % | 5.0 | 13.0 | abnormal | nan |
| Neutrophils | 52.5 | % | 34.0 | 71.0 | nan | nan |
| Platelet Count | 37.0 | K/uL | 150.0 | 400.0 | abnormal | ___ |
| Platelet Smear | nan | nan | nan | nan | nan | VERY LOW. |
| RDW | 13.7 | % | 10.5 | 15.5 | nan | nan |
| Red Blood Cells | 4.4 | m/uL | 4.6 | 6.1 | abnormal | nan |
| White Blood Cells | 3.3 | K/uL | 4.0 | 10.0 | abnormal | nan |
| Absolute Basophil Count | 0.01 | K/uL | 0.01 | 0.08 | nan | nan |
| Absolute Eosinophil Count | 0.03 | K/uL | 0.04 | 0.54 | abnormal | nan |
| Absolute Monocyte Count | 0.62 | K/uL | 0.2 | 0.8 | nan | nan |
| Absolute Neutrophil Count | 1.71 | K/uL | 1.6 | 6.1 | nan | nan |
| Immature Granulocytes | 0.3 | % | nan | nan | nan | nan |
| RDW-SD | 48.3 | fL | 35.1 | 46.3 | abnormal | nan |
| INR(PT) | 1.2 | nan | 0.9 | 1.1 | abnormal | nan |
| PT | 13.4 | sec | 9.4 | 12.5 | abnormal | nan |
| PTT | 35.3 | sec | 25.0 | 36.5 | nan | nan |

## Medrecon [2162-01-04 23:20:00]
| Name | Atc Type |
| ------ | ------ |
| omeprazole | omeprazole |
| tenofovir disoproxil fumarate [Viread] | nan |

## Vitalsign [2162-01-04 23:28:00]
| Temperature | Heartrate | Resprate | O2Sat | Sbp | Dbp | Pain | Rhythm |
| ------ | ------ | ------ | ------ | ------ | ------ | ------ | ------ |
| 99.1 | 76.0 | nan | 99.0 | 97.0 | 61.0 | nan | nan |
| nan | 76.0 | nan | 99.0 | 109.0 | 65.0 | nan | nan |
| nan | 72.0 | 16.0 | 98.0 | 102.0 | 61.0 | unable | nan |
| nan | 76.0 | 16.0 | 98.0 | 100.0 | 54.0 | nan | nan |

## Radiology Examinations [2162-01-05 00:35:00]
- Note_Type: RR
- Exam_Name: ['CT HEAD W/O CONTRAST']
- Text: EXAMINATION:  CT HEAD W/O CONTRAST

INDICATION:  History: ___ with headache, thrombocytopenia  // sdh?

TECHNIQUE:  Contiguous axial images from skullbase to vertex were obtained
without intravenous contrast.  Coronal and sagittal reformats were also
performed.

DOSE:   This study involved 3 CT acquisition phases with dose indices as
follows:
   1) CT Localizer Radiograph
   2) CT Localizer Radiograph
   3) Sequenced Acquisition 16.0 s, 16.1 cm; CTDIvol = 55.6 mGy (Head) DLP =
891.9 mGy-cm.
 Total DLP (Head) = 892 mGy-cm.

COMPARISON:  None.

FINDINGS: 

There is no intra-axial or extra-axial hemorrhage, mass, midline shift, or
acute major vascular territorial infarct.  Gray-white matter differentiation
is preserved.  Ventricles are symmetric and unremarkable.  Basilar cisterns
are patent.

Included paranasal sinuses and mastoids are clear.  Skull and extracranial
soft tissues are unremarkable.

IMPRESSION:


1. No acute intracranial process.


## Electronic Medicine Administration Record [2162-01-05 01:25:00]
- Medication: nan
- Event_Txt: Administered

## Vitalsign [2162-01-05 02:18:00]
| Temperature | Heartrate | Resprate | O2Sat | Sbp | Dbp | Pain | Rhythm |
| ------ | ------ | ------ | ------ | ------ | ------ | ------ | ------ |
| nan | 76.0 | 16.0 | 99.0 | 99.0 | 59.0 | nan | nan |
| 98.8 | 74.0 | 16.0 | 99.0 | 96.0 | 60.0 | nan | nan |

## Pyxis [2162-01-05 03:16:00]
| Name |
| ------ |
| Doxycycline Hyclate |
| Doxycycline Hyclate |

## Electronic Medicine Administration Record [2162-01-05 03:18:00]
- Medication: Doxycycline Hyclate
- Event_Txt: Administered

## Vitalsign [2162-01-05 03:32:00]
| Temperature | Heartrate | Resprate | O2Sat | Sbp | Dbp | Pain | Rhythm |
| ------ | ------ | ------ | ------ | ------ | ------ | ------ | ------ |
| nan | 74.0 | 18.0 | 98.0 | 110.0 | 68.0 | nan | nan |
| 100.0 | 80.0 | nan | 98.0 | 121.0 | 67.0 | nan | nan |
| 98.9 | 78.0 | 18.0 | 96.0 | 105.0 | 60.0 | 1 | nan |

## ED Diagnoses on International Classification of Diseases [2162-01-05 06:12:00]
- Icd_Title: LYME DISEASE
- Ccs Type: Other infections; including parasitic

## Online Medical Record [2162-01-16 00:00:00]
| Result_Name | Result_Value |
| ------ | ------ |
| Blood Pressure | 102/68 |
| Blood Pressure | 100/68 |
| BMI (kg/m2) | 22.9 |
| Weight (Lbs) | 142 |
| BMI (kg/m2) | 23.4 |
| Weight (Lbs) | 145 |

## Labotary Test Events [2162-03-07 15:40:00]
| Item_Name | Valuenum | Valueuom | Ref_Range_Lower | Ref_Range_Upper | Flag | Comments |
| ------ | ------ | ------ | ------ | ------ | ------ | ------ |
| Absolute Lymphocyte Count | 1.24 | K/uL | 1.2 | 3.7 | nan | nan |
| Basophils | 0.3 | % | 0.0 | 1.0 | nan | nan |
| Eosinophils | 2.5 | % | 1.0 | 7.0 | nan | nan |
| Hematocrit | 40.4 | % | 40.0 | 51.0 | nan | nan |
| Hemoglobin | 13.4 | g/dL | 13.7 | 17.5 | abnormal | nan |
| Lymphocytes | 34.4 | % | 19.0 | 53.0 | nan | nan |
| MCH | 32.0 | pg | 26.0 | 32.0 | nan | nan |
| MCHC | 33.2 | g/dL | 32.0 | 37.0 | nan | nan |
| MCV | 96.0 | fL | 82.0 | 98.0 | nan | nan |
| Monocytes | 8.9 | % | 5.0 | 13.0 | nan | nan |
| Neutrophils | 53.6 | % | 34.0 | 71.0 | nan | nan |
| Platelet Count | 55.0 | K/uL | 150.0 | 400.0 | abnormal | nan |
| RDW | 14.5 | % | 10.5 | 15.5 | nan | nan |
| Red Blood Cells | 4.19 | m/uL | 4.6 | 6.1 | abnormal | nan |
| White Blood Cells | 3.6 | K/uL | 4.0 | 10.0 | abnormal | nan |
| Absolute Basophil Count | 0.01 | K/uL | 0.01 | 0.08 | nan | nan |
| Absolute Eosinophil Count | 0.09 | K/uL | 0.04 | 0.54 | nan | nan |
| Absolute Monocyte Count | 0.32 | K/uL | 0.2 | 0.8 | nan | nan |
| Absolute Neutrophil Count | 1.93 | K/uL | 1.6 | 6.1 | nan | nan |
| Immature Granulocytes | 0.3 | % | nan | nan | nan | nan |
| RDW-SD | 50.8 | fL | 35.1 | 46.3 | abnormal | nan |
| INR(PT) | 1.1 | nan | 0.9 | 1.1 | nan | nan |
| PT | 12.2 | sec | 9.4 | 12.5 | nan | nan |
| Alanine Aminotransferase (ALT) | 26.0 | IU/L | 0.0 | 40.0 | nan | nan |
| Albumin | 4.2 | g/dL | 3.5 | 5.2 | nan | nan |
| Alkaline Phosphatase | 83.0 | IU/L | 40.0 | 130.0 | nan | nan |
| Alpha-Fetoprotein | 3.7 | ng/mL | 0.0 | 8.7 | nan | MEASURED BY ___. |
| Asparate Aminotransferase (AST) | 31.0 | IU/L | 0.0 | 40.0 | nan | nan |
| Bilirubin, Direct | 0.2 | mg/dL | 0.0 | 0.3 | nan | nan |
| Bilirubin, Indirect | 0.5 | mg/dL | nan | nan | nan | nan |
| Bilirubin, Total | 0.7 | mg/dL | 0.0 | 1.5 | nan | nan |
| Creatinine | 1.1 | mg/dL | 0.5 | 1.2 | nan | nan |
| Estimated GFR (MDRD equation) | nan | nan | nan | nan | nan | Using this patient's age, gender, and serum creatinine value of 1.1,.  Estimated GFR = 65 if non African-American (mL/min/1.73 m2).  Estimated GFR = >75 if African-American (mL/min/1.73 m2).  For comparison, mean GFR for age group 70+ is 75 (mL/min/1.73 m2).  GFR<60 = Chronic Kidney Disease, GFR<15 = Kidney Failure. |
| Globulin | 3.1 | g/dL | 2.0 | 4.0 | nan | nan |
| Protein, Total | 7.3 | g/dL | 6.4 | 8.3 | nan | nan |
| Urea Nitrogen | 19.0 | mg/dL | 6.0 | 20.0 | nan | nan |

## Microbiology Test Events [2162-03-07 15:40:00]
- Test_Name: HBV Viral Load
- Dilution_Text: nan
- Interpretation: nan
- Comments: HBV DNA detected, less than 20 IU/mL.  Performed using the ___ HBV Test v2.0.  Linear range of quantification: 20 IU/mL - 170 million IU/mL.  Limit of detection: 20 IU/mL.  
- Ab_Name: nan

## Radiology Examinations [2162-03-29 11:22:00]
- Note_Type: RR
- Exam_Name: ['MRI LIVER W&W/O CONTRAST']
- Text: EXAMINATION:  MRI of the Abdomen

INDICATION:  ___ year old man with chronic HBV and elevated AFP. AFP normalized
but prior MRI reported new liver lesion, also pancreatic cyst (IPMN), reassess
liver lesion for interval change, IPMN.

TECHNIQUE:  T1- and T2-weighted multiplanar images of the abdomen were
acquired in a 1.5 T magnet.
Intravenous contrast: 7 mL Gadavist.

COMPARISON:  MRI abdomen ___.

FINDINGS: 

Lower Thorax: There is no pleural or pericardial effusion.

Liver: The liver is shrunken and nodular, compatible with cirrhosis.  Again
seen superiorly in segment IV-A/VIII is a 2.5 x 1.9 cm arterially
hyperenhancing focus which demonstrates washout on more delayed phase
post-contrast images, with evidence of a pseudocapsule (series 107 image 86),
consistent with mild interval enlargement of known lesion meeting OPTN 5B
criteria for HCC (previously 2.2 x 1.6 cm when measured in a similar fashion).
A left hepatic lobe, segment IV-A/II 0.8 x 0.8 cm focus of arterial
enhancement again demonstrates isointensity on more delayed phase
post-contrast images, however appears larger since prior, again without a T2
correlate (series 100, image 21).  Multiple scattered, circumscribed,
nonenhancing T2 hyperintense foci measuring up to 0.6 cm are compatible with
biliary hamartomas or simple hepatic cysts.  The portal vein is patent.

Biliary: The gallbladder is unremarkable.  There is no intra- or extrahepatic
biliary ductal dilation.

Pancreas: A 4 mm circumscribed, nonenhancing T2 hyperintensity in the
pancreatic head is stable, compatible with a side-duct IPMN.  Otherwise come
the pancreas demonstrates normal homogeneous signal intensity.  There is no
main pancreatic ductal dilation.

Spleen: There is mild splenomegaly, as on prior exam.  No focal splenic
lesions are seen.

Adrenal Glands: The adrenal glands are normal in size and configuration.

Kidneys:  Again seen are scattered tiny bilateral simple renal cysts. 
Otherwise, the kidneys display normal symmetric enhancement and signal
intensity characteristics.  There is no hydronephrosis.

Gastrointestinal Tract:  The stomach and duodenum are unremarkable.  Partially
imaged non-dilated small bowel loops are normal in course and caliber without
evidence of wall thickening, mural or mucosal hyperenhancement, or
obstruction. The partially imaged colon is unremarkable.

Lymph Nodes: There is no evidence of retroperitoneal or mesenteric
lymphadenopathy.

Vasculature: Numerous dilated upper abdominal and perisplenic varices, in
addition to a splenorenal shunt, are indicative of portal hypertension.  The
abdominal aorta is normal in caliber without evidence of aneurysm or dilation.
Major proximal tributaries are patent.

Osseous and Soft Tissue Structures: No suspicious foci of abnormal marrow
signal are seen.

IMPRESSION:


1. Interval enlargement of a now 2.5 x 1.9 cm arterially-hyperenhancing
segment IV-A/VIII lesion meeting OPTN 5B criteria for ___, previously 2.2 x
1.6 cm in ___.
2. Interval enlargement of a left hepatic lobe 0.8 x 0.8 cm arterially
hyperenhancing focus without correlate on other sequences; although possibly a
perfusional anomaly, given interval enlargement, bears watching on follow-up
imaging.
3. Cirrhotic hepatic morphology.  Sequelae of portal hypertension, including
mild splenomegaly, splenorenal shunt, and upper abdominal and perisplenic
varices.  Patent portal vein.  No ascites seen.
4. Stable 4 mm pancreatic head cyst, likely a side-branch IPMN.


## Online Medical Record [2162-04-07 00:00:00]
| Result_Name | Result_Value |
| ------ | ------ |
| Blood Pressure | 98/53 |
| BMI (kg/m2) | 23.8 |
| Height (Inches) | 65 |
| Weight (Lbs) | 143 |

## Labotary Test Events [2162-04-14 08:20:00]
| Item_Name | Valuenum | Valueuom | Ref_Range_Lower | Ref_Range_Upper | Flag | Comments |
| ------ | ------ | ------ | ------ | ------ | ------ | ------ |
| Absolute Lymphocyte Count | 0.92 | K/uL | 1.2 | 3.7 | abnormal | nan |
| Basophils | 0.6 | % | 0.0 | 1.0 | nan | nan |
| Eosinophils | 1.8 | % | 1.0 | 7.0 | nan | nan |
| Hematocrit | 38.1 | % | 40.0 | 51.0 | abnormal | nan |
| Hemoglobin | 12.6 | g/dL | 13.7 | 17.5 | abnormal | nan |
| Lymphocytes | 27.8 | % | 19.0 | 53.0 | nan | nan |
| MCH | 31.8 | pg | 26.0 | 32.0 | nan | nan |
| MCHC | 33.1 | g/dL | 32.0 | 37.0 | nan | nan |
| MCV | 96.0 | fL | 82.0 | 98.0 | nan | nan |
| Monocytes | 5.4 | % | 5.0 | 13.0 | nan | nan |
| Neutrophils | 64.1 | % | 34.0 | 71.0 | nan | nan |
| Platelet Count | 56.0 | K/uL | 150.0 | 400.0 | abnormal | nan |
| RDW | 13.9 | % | 10.5 | 15.5 | nan | nan |
| Red Blood Cells | 3.96 | m/uL | 4.6 | 6.1 | abnormal | nan |
| White Blood Cells | 3.3 | K/uL | 4.0 | 10.0 | abnormal | nan |
| Absolute Basophil Count | 0.02 | K/uL | 0.01 | 0.08 | nan | nan |
| Absolute Eosinophil Count | 0.06 | K/uL | 0.04 | 0.54 | nan | nan |
| Absolute Monocyte Count | 0.18 | K/uL | 0.2 | 0.8 | abnormal | nan |
| Absolute Neutrophil Count | 2.12 | K/uL | 1.6 | 6.1 | nan | nan |
| Immature Granulocytes | 0.3 | % | nan | nan | nan | nan |
| RDW-SD | 49.4 | fL | 35.1 | 46.3 | abnormal | nan |
| INR(PT) | 1.1 | nan | 0.9 | 1.1 | nan | nan |
| PT | 12.0 | sec | 9.4 | 12.5 | nan | nan |
| Alanine Aminotransferase (ALT) | 26.0 | IU/L | 0.0 | 40.0 | nan | nan |
| Alkaline Phosphatase | 90.0 | IU/L | 40.0 | 130.0 | nan | nan |
| Asparate Aminotransferase (AST) | 36.0 | IU/L | 0.0 | 40.0 | nan | nan |
| Bilirubin, Total | 1.0 | mg/dL | 0.0 | 1.5 | nan | nan |
| Chloride | 104.0 | mEq/L | 96.0 | 108.0 | nan | nan |
| Creatinine | 1.1 | mg/dL | 0.5 | 1.2 | nan | nan |
| Estimated GFR (MDRD equation) | nan | nan | nan | nan | nan | Using this patient's age, gender, and serum creatinine value of 1.1,.  Estimated GFR = 65 if non African-American (mL/min/1.73 m2).  Estimated GFR = >75 if African-American (mL/min/1.73 m2).  For comparison, mean GFR for age group 70+ is 75 (mL/min/1.73 m2).  GFR<60 = Chronic Kidney Disease, GFR<15 = Kidney Failure. |
| Potassium | 3.9 | mEq/L | 3.3 | 5.1 | nan | nan |
| Sodium | 140.0 | mEq/L | 133.0 | 145.0 | nan | nan |
| Urea Nitrogen | 14.0 | mg/dL | 6.0 | 20.0 | nan | nan |

## Radiology Examinations [2162-04-19 09:14:00]
- Note_Type: RR
- Exam_Name: ['CT RFA LIVER 1 OR MORE', 'CT GUID/MONIT VISCERAL TISSUE ABLATION']
- Text: INDICATION:  ___ year old man with chronic Hep B now w
…[truncated]
```

## Assistant reply (full)
```
Looking at this patient's timeline, I need to determine what the next event would be after the lab results at 2163-03-21 14:00:00.

Key context:
- This is a 77-year-old male with chronic HBV, cirrhosis, and HCC (status post RFA)
- The most recent MRI (2163-02-07) showed a new 1.4 cm segment II mass meeting OPTN 5A-g criteria for HCC
- On 2163-03-21, there was a provider order entry for Lab and Blood Bank tests at 07:43:56
- Lab results came back at 14:00:00 showing pre-procedural labs (CBC, coags, liver function, creatinine, potassium)
- The labs look like pre-procedure workup (INR, PT, CBC, metabolic panel) - consistent with preparation for another interventional procedure (likely another RFA or similar liver-directed therapy for the new HCC lesion)
- Blood Bank order was also placed, suggesting a procedure is planned

Given that:
1. Pre-procedure labs and blood bank orders were placed on 2163-03-21
2. The patient has a new HCC lesion requiring treatment
3. The pattern from the previous RFA (2162-04-19) shows labs were drawn before the procedure

The next logical step would be the actual procedure - which would be documented as a radiology examination (similar to the CT-guided RFA performed on 2162-04-19). Looking at the candidate answers, "radiology" fits as the next event, as the interventional radiology procedure (likely another RFA) would follow the pre-procedure labs.

<answer>radiology</answer>
```